Physicochemical and functional properties of murine B cell-derived B cell growth factor II (WEHI-231-BCGF-II). 1985

K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto

A murine B lymphoma cell line, WEHI-231, constitutively secreted a kind of B cell stimulatory factor (BSF) that induced proliferation and IgM secretion in splenic B cells as well as BCL1 cells. Growth- and differentiation-promoting activities were not separated by various kinds of chromatographies on the basis of the m.w., isoelectric point, or hydrophobicity, and the degree of both activities in crude supernatants, DEAE-Toyopearl, TSK-3,000SWG, Mono P, and Phenyl-5PW fractions increased in a dose-dependent manner with complete correlation. The partially purified factor (WEHI-231-BGDF) did not show any other activities, such as IL 1, IL 2, interferon, or colony stimulating factor. WEHI-231-BGDF induced proliferation and IgM secretion in activated B cells with low density, but not in small resting B cells. WEHI-231-BGDF showed synergistic effect with dextran sulfate but not with anti-Ig in the induction of proliferation or IgM secretion in small resting B cells. WEHI-231-BGDF did not show any effect on Xid B cells. The relationship with several T cell-derived BSF and the significance of B cell-derived BSF in the B cell responses are discussed.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries

Related Publications

K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
June 1981, Journal of immunology (Baltimore, Md. : 1950),
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
July 1986, Journal of immunology (Baltimore, Md. : 1950),
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
June 1983, Journal of immunology (Baltimore, Md. : 1950),
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
March 1995, FEBS letters,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
May 1994, Cellular immunology,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
November 1987, Cellular immunology,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
August 1996, Journal of autoimmunity,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
June 1985, Cellular immunology,
K Nakajima, and T Hirano, and F Takatsuki, and N Sakaguchi, and N Yoshida, and T Kishimoto
September 1996, Molecular and cellular biology,
Copied contents to your clipboard!